Anti arrythmics

Classification ,[object Object],[object Object],[object Object],[object Object]

Class 1 ,[object Object],[object Object],[object Object]

Class 1A ,[object Object],[object Object],[object Object]

Action of 1A ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Use of 1A ,[object Object],[object Object]

Effects ,[object Object],[object Object],[object Object],[object Object]

Quinidine ,[object Object],[object Object],[object Object],[object Object]

Quinidine on ECG ,[object Object],[object Object],[object Object]

MOA of quinidine ,[object Object],[object Object],[object Object],[object Object],[object Object]

Use of quinidine ,[object Object],[object Object]

ADR ,[object Object],[object Object],[object Object]

interactions ,[object Object],[object Object],[object Object],[object Object]

Procainamide ,[object Object],[object Object]

Difference form quinidine ,[object Object],[object Object],[object Object],[object Object]

PK ,[object Object],[object Object],[object Object],[object Object],[object Object]

Major side effect of Procainamide ,[object Object],[object Object],[object Object]

Dysopyramide ,[object Object],[object Object],[object Object],[object Object],[object Object]

Class 1B ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Lignocaine-Lidocaine ,[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

MOA of lignocaine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pk ,[object Object],[object Object],[object Object]

ADR—of lignocaine ,[object Object],[object Object],[object Object]

Use of lignocaine ,[object Object],[object Object],[object Object],[object Object]

1c ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Recommended